Thus, the gradual loss of IL-24 expression as melanocytes transform into aggressive melanoma cells and the regained expression of IL-24 in terminally differentiated melanoma cells may well be explained by differentiation-associated alterations in the activity of p38 MAPK, its downstream kinases and RNA-binding proteins. The gene discussed is IL24; the disease is melanoma.